View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
November 7, 2011

Medtronic commences transcatheter valve trial

Medtronic has implanted the first patient with its CoreValve system in a clinical trial in Japan.

Medtronic has implanted the first patient with its CoreValve system in a clinical trial in Japan.

The trial will evaluate the safety and effectiveness of the Medtronic CoreValve system in patients with symptomatic, severe aortic stenosis who are at high risk or are ineligible for open-heart surgery.

The trial is being led by Professor Yoshiki Sawa at Osaka University Hospital.

The company also received Korea Food & Drug Administration approval for its CoreValve system last month.

Medtronic vice-president John Liddicoat said the successful results from the Japanese and Korean trials form the key steps for the transcatheter valve therapies to patients suffering from severe aortic stenosis.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management